INO — Inovio Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Inovio Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	89.5	412	401	253	145
Net Total Accounts Receivable
Net Total Receivables	2.03	19.1	8.03	11.7	2.41
Prepaid Expenses
Total Current Assets	94.2	471	448	315	153
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	26.6	24.1	29	18	14.5
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	144	540	496	349	171
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32	41.7	65.7	96.9	42.6
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	141	78.6	96.3	126	53.6
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	3.44	461	400	222	117
Total Liabilities & Shareholders' Equity	144	540	496	349	171
Total Common Shares Outstanding
Total Preferred Shares Outstanding